1. Home
  2. ELDN vs EFSI Comparison

ELDN vs EFSI Comparison

Compare ELDN & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • EFSI
  • Stock Information
  • Founded
  • ELDN 2004
  • EFSI 1881
  • Country
  • ELDN United States
  • EFSI United States
  • Employees
  • ELDN N/A
  • EFSI N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • EFSI Major Banks
  • Sector
  • ELDN Health Care
  • EFSI Finance
  • Exchange
  • ELDN Nasdaq
  • EFSI Nasdaq
  • Market Cap
  • ELDN 178.4M
  • EFSI 161.4M
  • IPO Year
  • ELDN N/A
  • EFSI N/A
  • Fundamental
  • Price
  • ELDN $2.72
  • EFSI $29.26
  • Analyst Decision
  • ELDN Strong Buy
  • EFSI Strong Buy
  • Analyst Count
  • ELDN 2
  • EFSI 2
  • Target Price
  • ELDN $12.50
  • EFSI $40.00
  • AVG Volume (30 Days)
  • ELDN 198.6K
  • EFSI 18.4K
  • Earning Date
  • ELDN 08-18-2025
  • EFSI 04-25-2025
  • Dividend Yield
  • ELDN N/A
  • EFSI 4.25%
  • EPS Growth
  • ELDN N/A
  • EFSI N/A
  • EPS
  • ELDN N/A
  • EFSI 1.52
  • Revenue
  • ELDN N/A
  • EFSI $58,067,000.00
  • Revenue This Year
  • ELDN N/A
  • EFSI $3.16
  • Revenue Next Year
  • ELDN N/A
  • EFSI $22.35
  • P/E Ratio
  • ELDN N/A
  • EFSI $19.12
  • Revenue Growth
  • ELDN N/A
  • EFSI N/A
  • 52 Week Low
  • ELDN $2.30
  • EFSI $28.70
  • 52 Week High
  • ELDN $5.54
  • EFSI $36.93
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 35.43
  • EFSI N/A
  • Support Level
  • ELDN $2.76
  • EFSI N/A
  • Resistance Level
  • ELDN $2.90
  • EFSI N/A
  • Average True Range (ATR)
  • ELDN 0.16
  • EFSI 0.00
  • MACD
  • ELDN -0.03
  • EFSI 0.00
  • Stochastic Oscillator
  • ELDN 4.39
  • EFSI 0.00

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About EFSI Eagle Financial Services Inc Common Stock

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

Share on Social Networks: